New scan and dye combo may spot hidden cancer in lymph nodes
NCT ID NCT01737619
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether combining a special scan (PET/CT) with a dye that highlights lymph nodes can better detect cancer spread in women with high-risk endometrial cancer. About 100 women scheduled for surgery will get both tests before their operation. The goal is to see if these methods can reduce the need for extensive lymph node removal during surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CLEAR CELL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lyndon Baines Johnson General Hospital
Houston, Texas, 77026-1967, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
MD Anderson Regional Care Center-Bay Area
Nassau Bay, Texas, 77058, United States
-
MD Anderson Regional Care Center-Katy
Houston, Texas, 77094, United States
-
MD Anderson Regional Care Center-Sugar Land
Sugar Land, Texas, 77478, United States
-
MD Anderson Regional Care Center-The Woodlands
The Woodlands, Texas, 77384, United States
-
The Woman's Hospital of Texas
Houston, Texas, 77054, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Common diabetes and acne drugs tested against cancer
- Experimental drug triapine tested in rare uterine cancer before surgery
- New tracer injection could sharpen cancer detection in lymph nodes
- Could a shorter radiation course be just as good for endometrial cancer?
- Experimental drug duo targets Hard-to-Treat cancers
- New hope for advanced endometrial cancer: three-drug combos tested in major trial